Key Developments For Cerner Corporation
Cerner Corporation (CERN.O) (Nasdaq)
Cerner Corporation Issues Q4 2009 Outlook; Revenue Outlook Below Analysts' Estimates
Cerner Corporation announced that for the fourth quarter of 2009, it anticipates revenue between $435 and $465 million and adjusted diluted earnings per share (EPS) before stock options expense between $0.68 and $0.74. SFAS No. 123R share-based compensation expense to reduce diluted earnings per share by approximately $0.03 to $0.04 in the fourth quarter of 2009. According to Reuters Estimates, analysts on an average were expecting the Company to report EPS of $0.70 on revenue of $473 million for the same period.
Cerner Corporation Says FDA Cleared Marketing Of System Combining Health Data On Mother And Fetus-AP
The Associated Press reported that Cerner Corporation said it received approval to sell a fetal monitoring system that coordinates data on both the mother and fetus. Cerner said the system, called FetaLink, combines data that can be used to create a fuller record of the mother and fetus' health. FetaLink documents and displays the relationship between fetal heart rates and contractions, and will allow clinicians to compare current data to information from earlier in the pregnancy or previous pregnancies.
Cerner Corporation Receives FDA Clearance for ProVision Workstation
Cerner Corporation announced that it has created the ProVision Workstation - Mammography solution, which recently received 510(k) pre-market clearance from the U.S. Food and Drug Administration (FDA) and is now available in North America.
Cerner Corporation Issues Q3 2009 Guidance; Revenue Guidance Below Analysts' Estimates; Reaffirms FY 2009 Guidance
Cerner Corporation announced that for third quarter of 2009, it expects revenue between $410-$430 million and adjusted diluted earnings per share (EPS) before stock options expense between $0.57-$0.63. For fiscal 2009, it expects revenue between $1.7-$1.75 billion and adjusted diluted earnings per share before stock options expense between $2.40-$2.50, which is unchanged from prior guidance. According to Reuters Estimates, analysts were expecting the Company to report revenues of $446 million for third quarter of 2009; revenues of $1.73 billion for fiscal 2009.
Cerner Corporation Issues Q2 2009 Guidance In Line With Analysts' Estimates; Reaffirms FY 2009 Guidance
Cerner Corporation announced that for second quarter 2009 it expects revenue between $415 million and $435 million, adjusted diluted earnings per share before stock options expense between $0.52 and $0.58. For fiscal 2009 it expects revenue between $1.75 billion and $1.80 billion, and adjusted diluted earnings per share before stock options expense between $2.40-$2.50, which is unchanged from prior guidance. According to Reuters Estimates, analysts are expecting the Company to report revenue of $433 million and EPS of $0.53 for second quarter 2009; revenue of $1.76 billion for fiscal 2009.
